EpiPen

Pfizer Inc. and two of its subsidiaries have agreed to pay $345 million under a proposed settlement to resolve litigation over EpiPen price hikes

Suburban college student Alexa Jordan says she got sick on a Boston to Chicago flight. Now she’s taken her push for epinephrine injectors to Washington.

The Food and Drug Administration said Tuesday that people can use some expired EpiPens for a few months longer to help cover spot shortages that have put some parents into a panic at the beginning of a new school year, NBC News reported. Some batches of the devices, which inject lifesaving medication to stop severe allergic reactions, can be used...

U.S. regulators cleared the first generic competitor to Mylan’s EpiPen, after a yearslong delay that many said contributed to the emergency allergy drug’s rapid rise in price. Teva Pharmaceuticals received Food and Drug Administration approval for generic versions of both the EpiPen and EpiPen Jr, the agency said in a statement Tuesday.

American taxpayers may have overpaid by as much as $1.27 billion for EpiPen anti-allergy devices over the course of a decade, a U.S. senator said Wednesday. That is nearly three times the $465 million that EpiPen’s owner, drugmaker Mylan, last October said it agreed to pay the federal government to settle claims it overcharged the government-run Medicaid system for the...

A recall of the emergency anti-allergy medicine EpiPen is expanding to the U.S. and other markets in North America, Europe, Asia and South America because the allergy shots may not work. The notice issued Friday by Mylan N.V. expands upon warnings made earlier this month after two reports of the device failing. Mylan didn’t immediately respond to a question about...

At $600 for two, no one wants to have to throw away their EpiPens because they got left in the car or elsewhere. The manufacturer says they should be kept at room temperature, so that’s why a Seattle mom and dad decided to create something that could allow an active lifestyle without the worry. “When we go outside with her…

The CEO of Mylan Pharmaceuticals announced the launch of its own cheaper version of the EpiPen this week on the heels of a price hike uproar. But for years, Mylan and its business partners have fought fiercely behind the scenes to block a cheaper generic from hitting the market, NBC New York’s I-Team reported. Documents reviewed by the I-Team show...

Mylan says it will make available a generic version of its EpiPen, as criticism mounts over the price of its injectable medicine. The company said Monday that its U.S. subsidiary will put out a generic version of the EpiPen that will have a list price of $300 for a two-pack — about half the current price. It will be available...

Parker took to Instagram on Thursday to distance herself from the company and urged it to “take swift action to lower the cost to be more affordable for whom it is a life-saving necessity.”

Doctors and patients say the pharmaceutical company Mylan has increased the prices for an EpiPen — the portable device that can stop a potentially life-threatening allergic reaction — from around $100 in 2008 to $500 or more today, NBC News reports. Following a recall by Mylan’s chief competitor last year, the company now enjoys a near monopoly. EpiPens have a...

Sanofi is recalling hundreds of thousands of epinephrine injectors used to treat severe allergic reactions because they may not deliver the correct amount of the life-saving drug.